Clinical trials
Observational Alzheimer Disease trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2022 | 3 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 3 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 4 |
| Central Clinical Hospital of the Russian Academy of Sciences | 1 |
| GE Healthcare | 1 |
| Hanze University of Applied Sciences Groningen | 1 |
| Indiana University | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Radboud University Medical Center | 1 |
| Stichting International Registry for Alzheimer's Disease and other Dementias Foundation | 1 |
| University Medical Center Groningen | 1 |
| University of Edinburgh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 14 |
| Cognitive Dysfunction | 5 |
| Dementia | 5 |
| Angina, Stable | 1 |
| Cerebrovascular Disorders | 1 |
| Cognition Disorders | 1 |
| Coronary Artery Disease | 1 |
| Delirium | 1 |
| Disease | 1 |
| Frailty | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.